Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boceprevir Strategies in HCV Genotype 1 IL28B CC Patients
NCT01544920Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- May 2012
- Primary completion
- May 2015
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of boceprevir in hepatitis C (HCV), sponsored by Merck & Co.. Started May 2012; status: completed.
02
Drugs
boceprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01544920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01544920.